Skip to content
SPC Logo

Entresto film-coated tablets

Last Updated on eMC 23-Mar-2017 View document  | Novartis Pharmaceuticals UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23-Mar-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Date of revision of text on the SPC: 16-Mar-2017

Legal Category:POM

Black Triangle (CHM): YES

Free-text change information supplied by the pharmaceutical company:

To increase the shelf life from 30 months to 3 years.

Updated on 01-Aug-2016 and displayed until 23-Mar-2017

Reasons for adding or updating:

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 10 - Date of revision of the text

Date of revision of text on the SPC: 16-Jun-2016

Legal Category:POM

Black Triangle (CHM): YES

Free-text change information supplied by the pharmaceutical company:

Update to section 4.5 to confirm that there is no clinically relevant DDI between Entresto and simvastatin.

Updated on 25-Feb-2016 and displayed until 01-Aug-2016

Reasons for adding or updating:

  • Change to section 6.5 - Nature and contents of container
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Date of revision of text on the SPC: 05-Feb-2016

Legal Category:POM

Black Triangle (CHM): YES

Free-text change information supplied by the pharmaceutical company:



Section 6.5

To add new pack sizes of 14, 20 or 56 for 24mg/26mg tablets.

To add new pack sizes of 14, 20 or 196 (7x28) for 49mg/51mg tablets.

To add new pack sizes of 14, 20 or 196 (7x28) for 97mg/103mg tablets.

Section 8

Add new MA numbers.

Updated on 01-Dec-2015 and displayed until 25-Feb-2016

Reasons for adding or updating:

  • New SPC for new product

Legal Category:POM

Black Triangle (CHM): YES

Company contact details

Novartis Pharmaceuticals UK Ltd

Company image
Address

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR

E-mail
Medical Information e-mail
Telephone

+44 (0)1276 692 255

Medical Information Direct Line

+44 (0)1276 698 370

Customer Care direct line

+44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

sacubitril , valsartan

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue